On 19 May 2020, Palestinian President Mahmoud Abbas announced that the Palestinian Authority (PA) considered itself absolved of all agreements and understandings it has signed with Israel and the United States. This decision was in response to Israels announcement of its intention to annex parts of the West Bank as early as 1 July, subject to the full agreement of the current U.S. administration. The threat of annexation has been widely condemned by the international community and the UN Secretary-General has stated that annexation would constitute a most serious violation of international law, grievously harm the prospect of a two-State solution and undercut the possibilities of a renewal of negotiations.
The PA has subsequently halted almost all bilateral contacts with Israel, including security coordination. The PA has also stopped accepting the clearance revenues that Israel collects on its behalf which, adding to the economic uncertainty caused by the COVID-19 pandemic, has resulted in a loss of about 80 per cent of its monthly revenues, and is limiting its capacity to pay employees salaries.
The suspension of coordination has already affected humanitarian operations across the occupied Palestinian territory (oPt), including preparedness and response to the COVID-19 pandemic. Since the beginning of June, the import of essential supplies by humanitarian agencies has been disrupted, affecting some of the major operational organizations, including the World Health Organization (WHO), the UN Childrens Fund (UNICEF), and the UN Development Programme (UNDP), in addition to some NGOs.
This Humanitarian Bulletin article, the first in a series addressing the implications of the halt in coordination between the PA and Israel, focuses on the access of Palestinian patients, in particular from the Gaza Strip, to health care in East Jerusalem and in Israel; two Gaza infants have died thus far, before their transfers to hospitals in Israel and in East Jerusalem, respectively, could be arranged.
Access to essential health care critically affected
Information and cases included in this section were provided by the World Health Organization (WHO)
Many Palestinian patients throughout the oPt, and their companions, require Israeli-issued permits to access essential health services unavailable in their locality. For residents of the Gaza Strip, permits are required to access hospitals in the West Bank, including East Jerusalem, as well as Israel and Jordan. In the West Bank, patients and their companions also require permits to enter East Jerusalem, Israel or Jordan. In 2019 each month, there were more than 7,000 patient permit applications from the West Bank (outside East Jerusalem), and over 2,000 from Gaza. Almost a third of applications are for persons with cancer. Approximately half of all referrals by the Palestinian Ministry of Health (MoH) were to hospitals in East Jerusalem.
Despite the cessation of permits coordination, patients and their families from the West Bank have been able to go in person to the Israeli District Coordination Office (DCO) to apply directly for permits. Additionally, the Israeli authorities are promoting a new mobile phone application, which Palestinians can download to apply for permits remotely, although concerns remain regarding the privacy and security implications of this system. Since the halt of coordination, there is no oversight of the application process for patients and companions, with limited means to track or record the number of those who apply; how many permits are denied or delayed; or to facilitate appeals on behalf of applicants.
In Gaza, although financial approvals for patient referrals are still issued, the PA has ended its coordination of permits requests for residents, including for patients and their companions. The issuance of referrals had already declined since the outbreak of COVID-19 in the oPt in March, following the Palestinian MoHs decision to reduce health services delivery in order to decrease transmission risk. This included efforts to localize some essential services, such as the short-term provision of limited chemotherapy through private providers in Gaza. In addition to the limitations imposed by the Palestinian authorities, the Israeli authorities further restricted eligibility criteria for exit permits, limiting those only to cancer patients and emergency cases. Consequently, in March, patient exits declined to 1,279, from a monthly average of 1,777 in January and February. April recorded only 159 applications, of which 113 were approved, and May, 160 applications, of which 105 were approved.
While restrictions eased after an initial decline in COVID-19 cases, the recent increase of cases in the West Bank and Israel may cause authorities to extend the limitations on exit from Gaza to prevent the occurrence of a community outbreak there.
The exit of a limited number of emergency cases had been facilitated through the intercession of the Palestinian Centre for Human Rights (PCHR), a Gaza-based NGO, among other organizations. Selma, a 64-year-old with Hodgkins Lymphoma, was referred to a West Bank hospital for self-stem cell transplant, a procedure unavailable in Gaza. With the help of PCHR, she obtained a permit to travel to the West Bank on 7 June, the day of her scheduled transplant operation. However, PCHR ended the facilitation of coordination of permits on 9 June, following an Israeli media report portraying the organization role as replacing the PAs role. Currently, a number of civil society organizations and hospitals are coordinating for patients referred for urgent treatment.
Osama, a one-year-old boy from Gaza City, was diagnosed with leukaemia on 8 June and referred urgently to Augusta Victoria Hospital in East Jerusalem for immediate treatment. Through the considerable efforts of hospital staff, he received a permit on 11 June, and he was able to travel to the hospital the same day.
Although Osamas mother was still breastfeeding him, he was accompanied by his grandmother on the grounds that older people find it easier to pass the security conditions required for permits. The medical team at Augusta Victoria Hospital reported his severe distress for days after his separation from his mother. Osamas father commented, We were told he is crying most of the time. Someone from the hospital has contacted me to try to coordinate a permit for Osamas mother to travel and be close to him, but we are still waiting.
The first fatality in Gaza following the halt in coordination was reported on 18 June, when eight-month-old Omar Yaghi, died of cardiac complications, before he was able to receive a permit to travel for an operation to Sheba Medical Center in Israel. On 22 June, a nine-day-old infant, Anwar Harb, who also suffered from heart problems, died before he could receive treatment in East Jerusalem. The Israeli authorities had agreed to his transfer to Al-Makassed Hospital that day, but the hospital was unable to coordinate the ambulance transfer in time.
Following the death of Omar Yaghi, a coalition of Israeli-based organizations sent an urgent letter to the Israeli Defence Minister, Attorney General, and the head of COGAT, demanding that Israel, as the occupying power, immediately ensure Palestinian travel through the Erez Crossing. The organizations specifically requested that Israel remove all bureaucratic restrictions on the submission of permit applications by patients and other humanitarian cases and allow Gaza residents to enter Israel and the West Bank immediately; immediately clarify how travel permit applications may be filed by Gaza residents; and publish clear, detailed, and accessible information about the alternative application procedure.
Roles and responsibilities of the parties
There have been suggestions that international organizations, particularly the UN, may be requested to perform the coordination activities, which the PA has been previous responsible for. However, as stated by UN Special Coordinator, Nikolay Mladenov, in his most recent briefing to the UN Security Council; while the UN is prepared to provide support on an emergency basis, the UN cannot replace the Palestinian Authority. It is critical that humanitarian and other assistance not be delayed or stopped.
The emergency support to be provided by the UN does not absolve Israel or the PA of their primary obligations towards the Palestinian population in the oPt. Under international law, Israel, as occupying power, bears the primary responsibility for the protection and welfare of this population, including access to essential health services. Even prior to the suspension of coordination, Palestinian patients, and their companions, faced major barriers to timely access to essential healthcare, due to delays and denials of the Israeli-issued permits needed for access to major specialist centres in East Jerusalem and in Israel.
The PA, having ratified human rights treaties, also has certain duties towards this population, within the limits of its control, as does the de facto authority in the Gaza Strip. These include ensuring respect and protection for the right to the highest attainable standard of health, and ensuring that policies introduced, or the withdrawal from previous responsibilities, do not cause harm.
Based on these considerations, the UN has agreed with both the Palestinian and Israeli authorities the establishment of a temporary mechanism, as part of which the UN will facilitate the transfer of the required documentation between the sides, to ensure access for Gaza patients to essential health services in the West Bank, including East Jerusalem, and Israel. This mechanism is expected to start operating during the second half of July.
 The only exception is coordination relating to the Kerem Shalom crossing for goods in and out of Gaza, which continues to operate as before.
 The majority of men over 55 years of age, and women over 50 from the remainder of the West Bank, as well as children 13 years and under, and accompanied by an adult, do not require permits to enter Israel or East Jerusalem.
- Study Finds Racial and Ethnic Disparities in Treatment of AL Amyloidosis - DocWire News - November 22nd, 2020
- New Virtual Reality Tool, Domestic Cats are SARS-CoV-2 Carriers, Combination Therapy Advances: COVID-19 Updates - Bio-IT World - November 22nd, 2020
- SEE | Smoking worsens Covid-19 infection in the airways, new study reveals - Health24 - November 22nd, 2020
- Could Cell Therapy Be The Answer To COVID-19? - CBS Boston - November 3rd, 2020
- CA Prop 14 Explained: What To Know Before You Vote Election Day - Los Angeles, CA Patch - November 3rd, 2020
- GMP Cell Banking Services Market Predicted to Accelerate the Growth by 2019-2029 - TechnoWeekly - November 3rd, 2020
- Making Progress Against Relapsed/ Refractory DLBCL Without CAR T - OncLive - November 3rd, 2020
- Orchard Therapeutics to Host Virtual R&D Investor Event on Friday, November 13, 2020 - GlobeNewswire - November 3rd, 2020
- Editorial Article: Combating cancer: The incubation technology accelerating CAR-T cell therapy development - SelectScience - October 31st, 2020
- Richters Transformation: When a Slow-Growing Cancer Turns Aggressive - SurvivorNet - October 31st, 2020
- Detroit Pistons, Make-A-Wish put a smile on the face of Commerce Township boy - The Oakland Press - October 31st, 2020
- NexImmune Establishes Research Initiative with City of Hope to Focus on Novel Immunotherapeutic Approaches to Acute Myeloid Leukemia - Yahoo Finance - October 31st, 2020
- HBS and Harvard's Department of Stem Cell and Regenerative Biology Receive $25 Million Gift from The Chris and Carrie Shumway Foundation to Support... - October 23rd, 2020
- Harnessing regeneration of retinal tissues: An option almost within reach - Ophthalmology Times - October 23rd, 2020
- Fate Therapeutics' and Celyad's CAR therapies in oncology offer potential - pharmaceutical-technology.com - October 23rd, 2020
- World Wide Stem Cell Treatment Centers Provides Exceptional Regenerative Treatment Options To Those in Need - GlobeNewswire - October 16th, 2020
- Proposition 14: Stem cell research bonds City Times - City Times - October 16th, 2020
- BrainStorm Announces Financial Results for the Third Quarter of 2020 and Provides a Corporate Update - PRNewswire - October 16th, 2020
- How a UCSF team is giving Cronutt the sea lion a second chance with neuroscience - University of California - October 16th, 2020
- Caliber Pain is Featured as a 2020 Top NYC Patient Rated Pain Management Practice by Find Local Doctors - PR Web - October 10th, 2020
- Report of the president: Appointments and promotions | Stanford News - Stanford University News - October 10th, 2020
- UTSW Scientist: 'We Need More Women Thinking Creatively in the Lab and Pushing Science Forward' - dallasinnovates.com - October 10th, 2020
- Here's what is known about Trump's COVID-19 treatment - Science Magazine - October 4th, 2020
- Election Guide: Here's What You Need to Know About Proposition 14 - NBC Bay Area - October 4th, 2020
- ASX up 2.3%, banks and energy outperform - The Sydney Morning Herald - October 4th, 2020
- Autologous Stem Cell and Non-Stem Cell Based Therapies MARKET 2020 |INDUSTRY ANALYSIS, SIZE, SHARE, TRENDS, MARKET DEMAND, GROWTH, OPPORTUNITIES AND... - September 25th, 2020
- Finding The Achilles Heel of A Killer Parasite - Newswise - September 25th, 2020
- SHE Initiative Shines Light on Gender Disparities in Oncology Workforce - Targeted Oncology - September 25th, 2020
- Actinium Pharmaceuticals Successfully Completes First Dosing Cohort in the Phase 1 Study of Actimab-A and Venetoclax Combination Therapy in... - September 23rd, 2020
- Advances in the Treatment of Mantle Cell Lymphoma are Greatly Improving the Long-Term Outlook for Patients - Curetoday.com - September 23rd, 2020
- CytoDyn's Phase 2 Study of Leronlimab for Mild-to-Moderate COVID-19 Selected for Oral Presentation at the Special isirv-AVG Virtual Conference on... - September 23rd, 2020
- Opdivo (nivolumab) Demonstrated Superior Disease-Free Survival in Patients with Resected Esophageal or Gastroesophageal Junction Cancer Compared to... - September 23rd, 2020
- Coronavirus Researchers Discover How COVID-19 May Trigger Fatal Levels of Lung Inflammation - SciTechDaily - September 21st, 2020
- The Holistic Sanctuary Announces Exciting Plans to Expand Over Next 4 Years and Save More Lives - PRNewswire - September 21st, 2020
- Robert E. Windsor, MD, is being recognized by Continental Who's Who - PRNewswire - September 21st, 2020
- City of Hope Enters Licensing Agreement With Chimeric to Develop Its Pioneering Chlorotoxin CAR T Cell Therapy - Business Wire - September 21st, 2020
- Emerging immunotherapies in multiple myeloma - The BMJ - September 21st, 2020
- ADC Therapeutics Submits Biologics License Application to the U.S. Food and Drug Administration for Loncastuximab Tesirine for Treatment of Relapsed... - September 21st, 2020
- Oakland 24-year-old seeking multiethnic bone marrow donor - The Jewish News of Northern California - September 21st, 2020
- First-Line Treatment With Merck's KEYTRUDA (pembrolizumab) Doubled Five-Year Survival Rate (31.9%) Versus Chemotherapy (16.3%) in Certain Patients... - September 21st, 2020
- Coronavirus, Charity, and the Trolley Problem - Crooked - September 12th, 2020
- Targeted Approach Considered for the Treatment of Accelerated/Blast Phase MPNs - Targeted Oncology - September 1st, 2020
- Royal Biologics Announces the Acquisition of FIBRINET - PRNewswire - September 1st, 2020
- Novel Targets Outside of JAK Inhibition Inching into Myelofibrosis Treatment Landscape - Targeted Oncology - September 1st, 2020
- MaaT Pharma to Announce Clinical Data with its Lead Microbiota Biotherapeutic in Intestinal Acute GvHD at Virtual 46th Annual Meeting of the European... - August 28th, 2020
- The Inside Story Of Biotechs Barnum And His Covid Cures - Forbes - August 28th, 2020
- Mustang Bio: Slow, Steady Progress Towards Multiple Gene And CAR-T Therapy Goals - Seeking Alpha - August 25th, 2020
- Study sheds light on why retinal ganglion cells are vulnerable to glaucoma - Jill Lopez - August 19th, 2020
- Coronavirus Thursday update: UMN announces new stem cell treatment - TwinCities.com-Pioneer Press - August 15th, 2020
- Health and Fitness: Hip replacement surgery: getting back to what you love - taosnews - August 14th, 2020
- How MC Hammer And Other Performing Artists Are Sharing Their Love Of Science - Forbes - August 12th, 2020
- Chromosomal Rearrangements Associated with Chemotherapeutic Drug Resistance | McDonnell Boehnen Hulbert & Berghoff LLP - JD Supra - August 8th, 2020
- Chinese Govt-Compensated Experts Plead Guilty to Thieving Investigation From an American Childrens Medi ... - 90Xtra - August 7th, 2020
- US government considers ethics of aborted tissue research - Angelus News - August 7th, 2020
- Mesa Discusses Treating Myelofibrosis and Other MPNs - Targeted Oncology - August 7th, 2020
- Startup Accelerator: Volumetric Aims to Be the Tissue Bioprinting Farm of the Future - 3DPrint.com - August 6th, 2020
- Cord blood offers hope for rare diseases and ethnic minorities - The Province - August 6th, 2020
- FDA touts advanced manufacturing to address Covid-19 shortfalls - Endpoints News - August 5th, 2020
- Cancer Research Institute Awards $30.2 Million in Grants and Fellowships to Support Basic and Clinical Research in Immunology and Cancer Immunotherapy... - August 5th, 2020
- RenovaCare Appoints Dr. Lydia M. Evans to Its Board of Directors and Increases Board Membership - GlobeNewswire - August 4th, 2020
- MediVet Biologics Rebrands as Ardent Animal Health - Benzinga - August 3rd, 2020
- Church Point Police Captain dies from COVID-19 complications: 'Go and protect the heavens, my dearest friend' - The Advocate - August 1st, 2020
- BMT survivor study finds significant breast cancer risk in young women who received total body irradiation - The Mix - July 31st, 2020
- Hyperbaric Oxygen Therapy Can Enhance Cognition in Healthy Older Adults - PsychCentral.com - July 29th, 2020
- The surprising recovery with stem cells of 26 COVID-19 patient in Hidalgo - Explica - July 29th, 2020
- Johnny Tabaie is proud to announce the most powerful Stem Cell Therapy - Press Release - Digital Journal - July 29th, 2020
- COVID-19 Fibroblast Based Cell Therapy Candidate Shown to Reduce Lung Scarring in Aggressive Animal Model - El Paso Inc. - July 25th, 2020
- 'Self-eating' process of stem cells may be the key to new regenerative therapies - 7thSpace Interactive - July 23rd, 2020
- R3 International Now Including Exosomes with Stem Cell Therapy Program for Autism in Mexico - PR Web - July 23rd, 2020
- CAR T-Cell Therapy Offers Potential Solution for Relapse in MCL, But With Toxicity Risk - Targeted Oncology - July 22nd, 2020
- Fine-tuning adoptive cell therapy for advanced cancers - Newswise - July 22nd, 2020
- Global Cart Cell Therapy Market To Grow At A CAGR of 29.4% With The Emergence Of Immunotherapies In Medical Treatment - GlobeNewswire - July 22nd, 2020
- In Remission for 10 Years: Long-term Data on CAR-T Therapy - Medscape - July 21st, 2020
- MRFR predicts an Upsurge in the Leukemia Therapeutics Market valuation to USD 10.7 billion by 2023 - Jewish Life News - July 21st, 2020
- Cannabis Found Effective to Treat Sickle Cell Disease Pain - The Weed Blog - July 20th, 2020
- Addiction Treatment Market Survey Report 2020 Stats and Forecasts to 2026 - Cole of Duty - July 18th, 2020
- 13 Promising Covid Treatments Emerging from Israel - The Jewish Voice - July 15th, 2020
- New Clues from Fruit Flies about the Critical Role of Sex Hormones in Stem Cell Control - Newswise - July 15th, 2020
- Impact of Covid-19 on Preimplantation Genetic Testing Market is Projected to Grow Massively in Near Future - Cole of Duty - July 13th, 2020
- Covid-19 Update : Cord Stem Cell Banking Market 2020 Outlook and Deep Study of Top Key Players Cryo-Save AG, Lifecell, StemCyte India Therapeutics... - July 13th, 2020